Lgnd stock zacks

LGND - Ligand Pharmaceuticals Incorporated Summary, Stock ...

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) issued its quarterly earnings data on Thursday, February, 6th. The biotechnology company reported $0.71 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.64 by $0.07. Ligand Pharmaceuticals Incorpor (LGND) Latest Stock News ... Get the latest Ligand Pharmaceuticals Incorpor (LGND) stock news and headlines to help you in your trading and investing decisions. Zacks. Ligand (LGND) Up 16.3% Since Last Earnings Report LGND Ligand Pharmaceuticals Incorporated Stock Quote Ligand Pharmaceuticals Inc (LGND) CEO John L Higgins Bought $285,725 of Shares GuruFocus.com: 09:30AM : LGND vs. ILMN: Which Stock Should Value Investors Buy Now? Zacks: Mar-13-19 09:11AM : Zacks.com featured expert Kevin Matras highlights: Sallie Mae, United Continental, Celgene and Ligand Pharmaceuticals Zacks

Ligand Pharmaceuticals Inc (LGND) CEO John L Higgins Bought $285,725 of Shares GuruFocus.com: 09:30AM : LGND vs. ILMN: Which Stock Should Value Investors Buy Now? Zacks: Mar-13-19 09:11AM : Zacks.com featured expert Kevin Matras highlights: Sallie Mae, United Continental, Celgene and Ligand Pharmaceuticals Zacks

Stock quote for Ligand Pharmaceuticals Incorporated Common Stock Common Stock (LGND) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Zacks: Analysts Anticipate Ligand Pharmaceuticals Inc ... 9 days ago · Equities analysts expect Ligand Pharmaceuticals Inc. (NASDAQ:LGND) to post earnings of $0.61 per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Ligand Pharmaceuticals’ earnings. Ligand Pharmaceuticals reported earnings of $1.16 per share during the same quarter last year, which suggests a negative year over year growth rate of 47.4%. […] Ligand (LGND) Up 16.3% Since Last Earnings Report: Can It ... Following the exact same course, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy. Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in. Outlook. Ligand has a Zacks Rank #5 (Strong Sell).

Ligand (LGND) Q4 Earnings & Revenues Top Estimates, Stock ...

Ligand Pharmaceuticals (LGND) came out with quarterly earnings of $0.49 per share, missing the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $1.32 per share a year ago. LGND Stock Quote - Ligand Pharmaceuticals Incorporated ...

Zacks: Brokerages Expect Ligand Pharmaceuticals Inc ...

LGND vs. ALKS: Which Stock Is the Better Value Option ... Jan 06, 2020 · LGND sticks out from ALKS in both our Zacks Rank and Style Scores models, so value investors will likely feel that LGND is the better option right now. LGND vs. ALKS: Which Stock Is the Better Value Option ... These metrics, and several others, help LGND earn a Value grade of B, while ALKS has been given a Value grade of C. LGND sticks out from ALKS in both our Zacks Rank and Style Scores models, so value investors will likely feel that LGND is the better option right now. Want the latest recommendations from Zacks Investment Research? Ligand Pharmaceuticals Incorporated - TheStreet Ligand Pharmaceuticals (LGND) Marked As A Dead Cat Bounce Stock. By TheStreet Wire. Oct 21, 2015 11:50 AM EDT. (LGND) Is Today's Strong And Under The Radar Stock. By TheStreet Wire.

Aug 29, 2017 · Zacks' 10-Minute Stock-Picking Secret Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it

LIGAND PHARMACEUTICALS Income Statement, Balance Sheet and Statement of Cash Flows. LIGAND PHARMACEUTICALS Key Stats, charts, historical data, comparisons and more at Zacks Advisor Tools. Brokerage Recommendations - Zacks Investment Research LGND: Ligand Pharmaceuticals Incorporated broker recommendations. Get the latest broker recommendations from Zacks Investment Research. Earnings Announcements - Zacks Investment Research LGND: Ligand Pharmaceuticals Incorporated - Earnings Announcements. Stay up to date with lastest Earnings Announcements for Ligand Pharmaceuticals Incorporated from Zacks Investment Research LGND Stock Price | Ligand Pharmaceuticals Inc. Stock Quote ...

Brokerage Recommendations - Zacks Investment Research LGND: Ligand Pharmaceuticals Incorporated broker recommendations. Get the latest broker recommendations from Zacks Investment Research. Earnings Announcements - Zacks Investment Research LGND: Ligand Pharmaceuticals Incorporated - Earnings Announcements. Stay up to date with lastest Earnings Announcements for Ligand Pharmaceuticals Incorporated from Zacks Investment Research LGND Stock Price | Ligand Pharmaceuticals Inc. Stock Quote ... LGND | Complete Ligand Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.